Moderna Stock Price Target Raised To 112 At Bmo Capital, Moderna Falls From Record As Euphoria Of Vaccine Data Wears Off

They currently have a market perform rating on the basic materials companys stock.

Vaccine trials covid 19 near me. The stock had previously closed at 6574. Premium brands holdings co. Nasdaqmrnas stock price rose 84 during mid day trading on thursday.

Valuengine raised celanese from a sell rating. Pbhto tsepbh had its price target raised by stock analysts at bmo capital markets from c10600 to c11200 in a research note issued on friday anlyst ratings reports. Several other equities analysts have also issued reports on ce.

Bmo capital markets target price would suggest a potential upside of 1095 from the stocks previous close. National bank financial raised their price target on premium brands holdings co. Celanese nysece had its target price increased by bmo capital markets from 11600 to 11900 in a report issued on tuesday morning anlyst ratings reports.

The company traded as high as 7454 and last traded at 7128. May 19 2020 0835 et. Approximately 13733438 shares were traded during trading a decline of 17 from the average daily volume of 16518338 shares.

Barclays raised norfolk southern from an underweight rating to. Prestige consumer healthcare nysepbh had its target price increased by equities researchers at bmo capital markets from 10600 to 11200 in a note issued to investors on friday stock target. A number of other equities analysts have also recently weighed in on mrna.

Nsc has been the subject of several other reports. Bmo capital markets currently has an outperform rating on the stock. The most enthusiastic investment bank price target hike so far 112 from bmo capital on tuesday suggests the biotech stocks climb to 80 on monday was just the beginning of a much larger run up.

Norfolk southern nysensc had its price objective hoisted by bmo capital markets from 22000 to 23000 in a report issued on thursday the fly reports. They currently have a market perform rating on the railroad operators stock. Moderna nasdaqmrna had its price objective increased by bmo capital markets from 9400 to 11200 in a research report sent to investors on monday morning the fly reports.

Back to news results moderna stock price target raised to 112 at bmo capital. 154 524 bid ask ba size days high 3413 days low 3060. The companys interim results from niaids phase 1 trial evaluating mrna 1273 as a covid 19 vaccine has meaningfully reduced clinical risk and should continue to generate investor interest in the program.

A number of other equities research analysts also recently weighed in on pbh. 835 am et may 19 2020 marketwatch print end dow jones newswires. Premium brands holdings co.